Percheron Therapeutics Ltd (per) Logo

Percheron Therapeutics Ltd (PER)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

PER ASX Chart

Snapshot

Percheron Therapeutics Limited (PER, formerly Antisense Therapeutics Limited) is a publicly listed biotechnology company focused on the development and commercialisation of novel therapies for oncology and rare diseases. The company's lead program is HMBD-002, a monoclonal antibody targeting the immune checkpoint regulator, VISTA.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -61.69%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,157 of 2,337
Sector Rank 208 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies BIT / BPH / ZLD
EPS -$0.008
DPS $0.00
Book Value Per Share $0.005

Broker Consensus

PER is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.percherontx.com
Registry BoardRoom
Auditor William Buck Audit (VIC) Pty Ltd
Date Listed 20 Dec 2001

Upcoming Calendar (Forecasted)

Date Event
27/08/2026 Report (Prelim)
27/08/2026 Report (Annual)
25/02/2027 Report (Interim)

Former Company Names

  • Antisense Therapeutics Limited (ANP), 03/01/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PER directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
15/04/26 James Garner Issued 21,400,000 $0.005 $107,000 Rights issue
15/04/26 James Garner Issued 10,700,000 $0.004 $42,800 Rights issue
22/12/25 Ben Price Buy +2,000,000 $0.009 $17,220 On-market trade
19/12/25 James Garner Buy +1,000,000 $0.009 $8,500 On-market trade
30/06/25 James Garner Buy +2,500,000 $0.01 $24,960 On-market trade
20/05/25 Charmaine Gittleson Issued 239,999 $0.035 $8,399 Issue of options
20/05/25 James Garner Issued 5,000,000 $0.035 $175,000 Issue of options
31/03/25 Ben Price Buy +5,000,000 $0.012 $58,121 On-market trade
28/03/25 James Garner Buy +7,500,000 $0.011 $81,870 On-market trade
18/03/25 Ben Price Expiry 1,000,000 $0.01 $10,000 Options expired
26/02/25 James Garner Buy +39,500,000 $0.012 $475,276 On-market trade
31/12/24 Charmaine Gittleson Buy +1,666,666 $0.009 $14,999 On-market trade
24/12/24 James Garner Buy +1,500,000 $0.007 $10,500 On-market trade
20/12/24 Charmaine Gittleson Expiry 6,667 $0.007 $46 Options expired
27/11/24 James Garner Buy +125,000 $0.071 $8,937 On-market trade
25/11/24 Ben Price Issued 3,000,000 $0.063 $189,000 Issue of options
25/11/24 James Garner Issued 3,000,000 $0.063 $189,000 Issue of options
14/11/24 James Garner Buy +375,000 $0.08 $30,000 Participation in share purchase plan

Director Interests

The current holdings of PER directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
James Garner 15/04/2026 74,900,000 N/A 25,390,000 N/A
Ben Price 22/12/2025 7,999,805 N/A 3,000,000 N/A
Charmaine Gittleson 30/06/2025 N/A 2,399,999 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 15, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited 75,135,889 6.91%
Dr James Stuart Garner 52,500,000 4.83%
Non Correlated Capital Pty Ltd <Investius Pb Micro Cap A/C> 50,000,000 4.60%
Powerhouse Ventures Limited 46,707,181 4.29%
Mr Glen Corby Bull 42,000,000 3.86%
Mutual Investments Pty Ltd <Mitchell Family A/C> 35,393,981 3.25%
BNP Paribas Nominees Pty Ltd <Clearstream> 26,307,270 2.42%
Mr Siddhartha Kantichand Dhadha 19,500,000 1.79%
Mutual Investments Pty Ltd <The Mitchell Super Fund A/C> 15,350,000 1.41%
Mr Dale Anthony Reed 15,050,000 1.38%
Jamplat Pty Ltd 14,999,000 1.38%
Citycastle Pty Ltd 12,183,036 1.12%
Mr Colin William Macleod & Mrs Linda Elizabeth Macleod <Macleod Super Fund A/C> 10,700,000 0.98%
Mikado Corporation Pty Ltd <Jfc Superannuation A/C> 10,000,000 0.92%
Shah Nominees Pty Ltd 10,000,000 0.92%
Shah Nominees Pty Ltd <Louis Carsten Super Fund A/C> 10,000,000 0.92%
Finclear Services Pty Ltd <Superhero Securities A/C> 9,584,204 0.88%
HSBC Custody Nominees (Australia) Limited A/C 2 8,542,111 0.80%
Mr Robertson Mclennan Mitchell & Mrs Karen Joy Mitchell 8,455,319 0.80%
Mrs Margaret Ann Ryan & Mr Micheal Rodney Ryan 8,000,000 0.70%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 81 100 335 1,611 880 3,007

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Mutual Investments Pty Ltd 15/08/2025 59,199,300 5.44

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.01 30 June
2024 $0.085 28 June
2023 $0.059 30 June
2022 $0.075 30 June
2021 $0.195 30 June
2020 $0.074 30 June
2019 $0.045 28 June
2018 $0.025 29 June
2017 $0.033 30 June
2016 $0.031 30 June
2015 $0.115 30 June
2014 $0.14 30 June
PER Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.